Left to reserve your spot!
Is a unique opportunity to receive CME credits while staying ahead of the latest advances in immuno and molecular oncology.
The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months, and features anticipated advances that you and your patients will likely see in the upcoming year.
The 2018 agenda has been curated to meet the educational needs of all attendees with an emphasis on the follow key areas:
Practical considerations of applying biomarkers and targeted therapy
Integration of immunotherapy, with a focus on novel management approaches
Patient selection, as well as timing and sequencing of therapy
Dealing with important trends, such a big data and defining value in cancer care
An elite faculty has been assembled for the 2018 Annual PRIMO Meeting by our Steering Committee, led by our Co-Chairs Dr. Brahmer, Dr. Rugo, and Dr. Vose